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Background: Glucocorticoid receptor (GR) is a hormone-activated, DNA-binding transcriptional regulatory factor
that controls inflammation, metabolism, stress responses, and other physiological processes. In vitro, GR binds as an
inverted dimer to a motif consisting of two imperfectly palindromic 6 bp half sites separated by 3 bp spacers. In
vivo, GR employs different patterns of functional surfaces of GR to regulate different target genes. The relationships
between GR genomic binding and functional surface utilization have not been defined.
Results: We find that A477T, a GR mutant that disrupts the dimerization interface, differs from wild-type GRα in
binding and regulation of target genes. Genomic regions strongly occupied by A477T are enriched for a novel half
site motif. In vitro, GRα binds half sites as a monomer. Through the overlap between GRα- and A477T-bound regions, we
identify GRα-bound regions containing only half sites. We further identify GR target genes linked with half sites and not
with the full motif.
Conclusions: Genomic regions bound by GR differ in underlying DNA sequence motifs and in the GR functional surfaces
employed for regulation. Identification of GR binding regions that selectively utilize particular GR surfaces may
discriminate sub-motifs, including the half site motif, that favor those surfaces. This approach may contribute to predictive
models for GR activity and therapy.Background
Glucocorticoid receptor (GR, HUGO symbol NR3C1) is
a DNA-binding transcriptional regulatory factor that
is activated specifically by binding glucocorticoid hor-
mones, and which regulates diverse aspects of physi-
ology. Genome-wide measurements of gene expression
in U2OS human osteosarcoma cells stably expressing
GR [1] have revealed that thousands of genes are differ-
entially expressed in response to glucocorticoid treat-
ment (that is, regulated by GR) [2]. Moreover, U2OS
lines stably expressing three mutant GR alleles, each
disrupting one functional surface, have revealed that dif-
ferent GR target genes depend on different patterns of
functional surfaces of GR for proper regulation; A477T
disrupts the dimerization interface; and 30iiB (E219K/
F220L/W234) and E773R disrupt the activation function 1
and 2 (AF1, AF2) domains, respectively (Figure 1A) [2].
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unless otherwise stated.isoform GRα by insertion of a single arginine in the ‘lever
arm’ region [3], differentially regulates some GR regulated
genes, implicating this region as another functional sur-
face. X-ray crystallography [3] and nuclear magnetic res-
onance spectroscopy (NMR) [4] of GR bound to different
oligonucleotides containing high-affinity binding sites in-
dicate that GR assumes distinct conformations at different
sites. These results imply that GR also assumes different
conformations in vivo at different glucocorticoid response
elements (GREs), genomic regions that confer specific
context-dependent GR responsiveness upon a nearby
gene.
In vitro, purified GR recognizes specifically a GR bind-
ing sequence (GBS) motif composed of imperfect palin-
dromic 6 base pair (bp) ‘half sites’ separated by 3 bp
‘spacers’, binding as an inverted dimer [5]. In vivo, GR oc-
cupies specific genomic GR binding regions (GBRs), iden-
tified using chromatin immunoprecipitation coupled with
quantitative PCR (ChIP) or deep sequencing (ChIP-seq).
The genomic locations of GBRs differ strikingly in differ-
ent cell or physiologic contexts, and not all GBRs contain
an identifiable GBS motif. Hence, the relationship betweenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 GR alleles used in this study. Rat GRα, the major isoform of GR, is a 795 amino acid protein with a modular structure typical of
nuclear receptors: an N-terminal activation function 1 (AF1) domain, a DNA-binding domain (DBD), and a C-terminal ligand binding domain
(LDB), which contains the activation function 2 (AF2) domain. We used mutations of GRα in AF1 (30iiB); AF2 (E773R); the dimerization interface of
the DBD (A477T); and a minor isoform GRγ, which bears a single amino acid (arginine) insertion at position 471 in GRα as a result of alternative
splicing. Domain boundaries are approximate, based on functional assays. Western blots show that GR was expressed at similar levels in all cell
lines, which were similar to the level of endogenous GR found in the lung adenocarcinomic human alveolar basal epithelial cell line A549.
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pied in vivo is complex. It is reassuring that GBS motifs
drive GR-regulated transcription in a simple reporter con-
text [5], and therefore reasonable to assume that GR occu-
pancy at GBRs that contain GBSs reflects in vivo sequence
recognition. Interestingly, different GBSs, tested in isola-
tion in vivo, trigger utilization of different patterns of GR
functional surfaces [3], supporting the notion that GR as-
sumes different conformations at these sequences in vivo.
However, rules dictating the relationship between DNA
sequence, GR conformation, and utilization of distinct GR
functional surfaces remain unknown.
We therefore examined whether sequence motifs, in-
cluding the canonical GBS, found within GBRs might in
fact be an aggregate of specific motifs, each biased to-
ward utilization of particular functional surfaces of GR.
In this study, we measured changes in gene expression
and genomic occupancy upon glucocorticoid treatment
of isogenic cultured human cell lines expressing alleles
of GR bearing differences in particular functional sur-
faces. We further used statistical, computational, and
biophysical methods to characterize changes in GR con-
formation and function, as well as the sequence motifs
that are present at GREs, in relation to these functional
surfaces.
Results
Different GR alleles induce diverse, gene-specific
transcriptional responses
To improve our understanding of the patterns of GR
functional surfaces used during transcriptional regula-
tion, we carried out a genome-wide analysis in a series
of human U2OS osteosarcoma cell lines with stably inte-
grated GR alleles [2,6]. We isolated RNA from U2OS
cells expressing integrated rat GRα, GRγ, GRα 30iiB
(30iiB; E219K/F220L/W234R), GRα A477T (A477T), orGRα E773R (E773R) (Figure 1A, B) after treatment for 2,
4, or 24 h with 100 nM dexamethasone, a synthetic
glucocorticoid that binds GR with high affinity, or for
4 h with ethanol only as a ‘0 hour’ control. Each GRα
mutation alters in a distinct way the utilization of vari-
ous GR regulatory surfaces; among cells expressing the
30iiB, A477T, or E773R mutations, a panel of 10 regu-
lated genes displayed six out of the eight possible pat-
terns of surface utilization of three surfaces compared to
GRα; that is, (2 states, utilizes or does not)(3 mutations) = 8
patterns [2]. These results imply that other functional
surfaces and a multitude of patterns are likely used at
regulated genes. We assayed all gene expression from
isolated RNA samples (Additional file 1). After 4 h of
dexamethasone treatment, thousands of genes were reg-
ulated by GR [2]. Because of the statistical complexities
with assessing utilization of each of the four GR surfaces
at every regulated gene, we instead analyzed pairwise the
regulation by GRα compared individually with our four
GR alleles (Additional file 1). As expected, we found that
regulation was affected in a highly allele-specific and
gene-specific manner (Additional file 1, Figure 2).
We calculated the statistical significance of the difference
in regulation between GRα and each allele for each gene
after 4 h of dexamethasone treatment (Figure 3A to D),
using limma, a software package for the analysis of gene
expression microarray data using linear models. We
instructed limma to estimate the regression coefficients
(that is, the per-gene differences in regulation between a
given allele and GRα) for each such simple contrast (the
difference of GRγ and GRα, and so on), as well as the
standard errors of those coefficients [7]. This method al-
lows the application of a t-test to determine significance,
which may reduce the number of identified targets but en-
sures a high confidence gene list by properly controlling
the false discovery rate [7].
Figure 2 Glucocorticoid regulation occurs with gene-specific utilization of GR functional surfaces. U2OS cells expressing GR alleles were
treated for 4 h with dexamethasone or vehicle (ethanol). Scatterplots of expression changes (log2-fold change) at 4 h are shown with the GRα
response (log2-fold change) on the x-axis and the response for another allele on the y-axis: A477T, GRγ, 30iiB, or E773R. Only genes with
significant (adjusted P <0.05) changes in expression are shown, as open circles: those with changes that were significant in GRα are pink, significant in
the other allele are green and significant in both are orange.
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each GR regulated gene based on its valence of regulation
by GRα (activation or repression) and the difference in
regulation by that allele and by GRα (gain, loss, or change
of valence). Some phenotypic classifications were less
common than others: in particular, genes that change the
valence of regulation were relatively rare. Moreover, cer-
tain phenotypes appeared to be relatively allele-restricted;
for example, many genes gained activation with A477T
and GRγ (103 and 36 genes, respectively), whereas few
gained activation with 30iiB or E773R (6 and 1 genes,
respectively) (Figure 3). Thus, A477T and GRγ may
drive activation through one or more mechanisms un-
available to GRα, 30iiB, or E773R.
A477T and GRγ selectively occupy GBRs near genes that
gain activation
Next, we performed ChIP-seq to define GBRs genome-
wide in U2OS cells expressing GRα or one of the three
mutant alleles (30iiB, A477T, and E773R), after treatment
with dexamethasone. Defining GBRs enables identification
of putative primary regulated genes (those regulated by a
proximal GR-occupied presumptive GRE) and allows us
to distinguish genes differentially regulated due to changes
in occupancy from those with altered GR activity. GRγhas been similarly examined by others [6]. Importantly,
we did paired-end sequencing of the ChIP-seq library,
which improves the dynamic range of occupancy by allow-
ing use of both ends of the double stranded molecule to
determine whether the originating fragment was unique
[8]. We identified GBRs (Additional file 2) using MACS2a,
a software package for the analysis of ChIP-seq data, and
assigned the GBRs to genes (Additional file 3) based on
proximity (see Materials and Methods, ‘GBR to gene as-
signment’) [9]. We also compared occupancy between
GRα and each mutant (Additional file 4 Additional file 5
and Additional file 6) using the ‘diffstats’ module of
MACS2 (see Materials and Methods, ‘Computational
analysis of ChIP-seq data’). To avoid considering the
same GBR twice, we considered all GBRs from GRα and
those GBRs from a given mutant that did not overlap
with GBRs from GRα (see Additional file 7, Additional
file 8, Additional file 9, and Additional file 10); addition-
ally, we analyzed only GBRs with signals of at least two
reads per million total reads.
Among cells expressing GRα or 30iiB, we found that
the locations of about 7% of GBRs differedb; and we
observed the same fractional difference among cells
expressing GRα or E773R. Similarly, the magnitude of
occupancy (that is, the number of observed sequence
Figure 3 Differential regulation analysis reveals distinct classes of regulated genes. Scatterplots of expression changes (log2-fold change)
at 4 h are shown (left) as in Figure 2. Genes with significant differences in regulation (differences in differences in expression) with a given allele
as compared to GRα are shown as filled circles with a black outline; genes lacking significant differences are shown as open circles. Only genes
with significant (adjusted P <0.05) regulation in at least one condition (GRα or a given allele) are shown. We categorized genes showing
significant differences in regulation (compared to GRα) by the functional consequence of the alternative allele/mutation (right).
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quarter of GBRs among cells expressing GRα, 30iiB, or
E773R (Figure 4C and D). In contrast, the locations of
over half of GBRs differedb among cells expressing
GRα or A477T (for example, Figure 4A). Moreover, the
magnitude of occupancy varied at most GBRs: more
than half had greater occupancy by GRα than by A477T
(GRα-selectively occupied) and one-quarter had greater
occupancy by A477T than by GRα (A477T-selectively oc-
cupied) (Figure 4B).
Comparing these results with our gene expression
findings, we observed substantial enrichment of GRα-
selectively occupied GBRs near genes that lost activation
in cells expressing A477T (Figure 4E, Additional file 11,
and Additional file 12), and of both A477T- and GRα-
selectively occupied GBRs near genes that gained activa-
tion (Figure 4F, Additional file 12, and Additional file 13).Thus, it appeared that the differentially regulated genes
represent a mixture, some with altered strength of occu-
pancy (that is, a direct relationship between binding and
regulation) and others with altered GR activity (that is,
an indirect relationship). The occupancy of A477T near
genes that are activated by A477T is surprising in light
of previous reports indicating that mutations in the
dimerization interface abrogate ‘transactivation’ [10,11].
We further investigated whether the differentially oc-
cupied GBRs near differentially regulated genes were re-
sponsible for the observed regulation. As a simple measure
of regulatory function, we cloned GBRs - selected on the
basis of proximity to differentially regulated genes, strength
of occupancy, and isolation from many other GBRs - into
luciferase-based reporters and transfected them into U2OS
cells expressing either GRα or A477T. We found GRα-
selective activation with four GRα-selectively occupied
Figure 4 Location, strength of occupancy, and inferred activity of GBRs compared pairwise between GRα and mutants. (A) Example of
allele-specific GBR location: HOXD1 gene displays proximal GRα-specific and A477T-specific GBRs. (B-D) Strength of occupancy: Pie charts of
relative magnitude of GBR occupancy (P <0.05) in pairwise comparisons of GRα relative to (B) A477T, (C) 30iiB, and (D) E773R: greater mutant
occupancy (blue), greater GRα occupancy (yellow) or not significantly different occupancy (grey). There was enrichment of GRα-selectively
occupied GBRs near genes that lost activation (E) in cells expressing A477T. Similarly, there was enrichment of A477T-selectively occupied GBRs
near genes that gained activation (F), although such genes also displayed enrichment for GRα-selectively occupied GBRs. The relative heights of
the enrichment curves (E and F) are proportional to the number of binding sites of each allele. In contrast, 30iiB and E773R GBRs were generally
similar to GRα GBRs in both location and strength of occupancy.
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selectively occupied GBRs, and non-selective activation
with five non-selectively occupied GBRs (Additional file 14).
Six of 24 GBRs did not activate transcription in either
cell line, but only two drove aberrant activation (op-
posing selectivity of occupancy and activation). These
results imply that certain of the differentially occupied
GBRs may indeed function to differentially regulate
nearby genes. Additional experiments, using recent
methods such as endogenous genome editing [12-15],
will be required to assess unequivocally whether a given
GBR is actually a GRE, and, if so, whether it confers differ-
ential regulation.Most A477T-selectively occupied GBRs contain a half site
motif
In order to understand what sequence constraints, if any,
were responsible for differential occupancy by GRα and
A477T, we performed motif analysis (Additional file 15)
using MEME-ChIP [16]. Three groups of GBRs were ana-
lyzed: (1) the thousand most-occupied GBRs that were oc-
cupied by GRα and did not have detectable occupancy by
A477T (‘GRα only’, Figure 5); (2) the thousand most-
occupied GBRs that were occupied by both GRα and
A477T with less than a 1.4-fold difference (‘GRα &
A477T’, Figure 5); and (3) the thousand most-occupied
GBRs that were occupied by A477T and did not have
Figure 5 Both A477T and GRα occupy ‘half site’ GBRs in vivo. Motif analysis was performed using MEME-ChIP on three groups of GBRs
(results shown by row): occupied by GRα only (top row), occupied by both GRα and A477T with ≤1.4-fold difference (second row), and occupied
by A477T only (third row). GR motifs (left column) from GBRs occupied by GRα only are similar to the canonical full site. In contrast, GR motifs
from GBRs occupied by A477T only consist of a ‘half site’ motif, which lack the second adjacent half site. GR motifs from GBRs occupied by both
GRα and A477T contain a very weak second half site, separated by the normal three bp spacer. GR motifs were forced to 17 bp in all samples,
but an unbiased search revealed shorter 11 bp motifs at GBRs occupied by GRα and A477T, or A477T alone (Additional file 10). GR motifs are
centrally enriched in all samples (P < <0.01). Motifs that were similar to those for STAT (center column) and AP1 (right column) family transcription
factors were also found, although the AP1 motif was not enriched at GBRs occupied by only A477T. The bottom row shows the JASPAR motifs
for STAT3 (MA0144.1) and AP1 (MA0099.2) as a reference, and the vertical dashed lines indicate their alignment with discovered motifs.
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excluded from motif analysis GBRs that overlap with
known repeats (see Materials and Methods, ‘Computa-
tional analysis of ChIP-seq data’).
De novo motif searches with MEME [17] revealed that
GBRs occupied by only GRα were enriched for the canon-
ical GR ‘full site’ motif, which specifies cooperative binding
as a GR dimer (Figure 5). Allowing MEME to determine
the optimal length for motifs in GBRs occupied by only
GRα revealed a 17 bp GR motif (Additional file 15), which
is longer than the previously reported 14 bp [18] and
15 bp motifs [19], having additional, asymmetric specificity
flanking the more strongly specified half site. In contrast,
GBRs occupied by only A477T were enriched for a single
half site motif (Figure 5), which may provoke binding of a
GR monomer to DNA. These results are consistent with
the observations that A477T has an impaired dimerization
interface and decreased cooperativity [4].
GBRs that were occupied by both GRα and A477T
were enriched for an intermediate motif that consistedof a closer-to-consensus half site and a very weak second
half site, separated by the normal 3 bp spacer (Figure 5).
Due to the semi-quantitative nature of ChIP-seq, some
GBRs that we characterized as similarly occupied by
both GRα and A477T may actually be differentially occu-
pied (and conversely, some GBRs that we characterized as
differentially occupied may not be). Therefore, the weak
second half site seen at GBRs occupied by both GRα and
A477T may be an experimental artifact; moreover, the
lack of a second half site motif at A477T-selectively occu-
pied GBRs implies that such GBRs indeed contain a motif
distinct from that found at GRα-occupied GBRs. Support-
ing this view, length-unbiased searches with MEME for
motifs at GBRs occupied by only A477T or both A477T
and GRα revealed truncated motifs that included only the
first two positions corresponding to the second half site
(Additional file 15). In Figure 5, we display GR motifs
found when forcing MEME to search for motifs that are
exactly 17 bp in length, for ease of comparison. CentriMo,
which searches for central/local enrichment of motifs in









STAT3 3,277 1,719 1.4
AP1 3,694 1,214 3.0
Found among all 23,525 GBRs in cells expressing GRα.
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enriched at GBR signal maxima (Additional file 15), im-
plying direct binding by GR at these GBRs.
Discriminatory motif analysis of the three different clas-
ses (GRα-selective, A477T-selective, and non-selective) of
occupied GBRs with DREME, which exhaustively searches
for all 3 to 8 bp regular expression motifs that are
enriched relative to di-nucleotide shuffled sequences [21],
revealed motifs similar to that of activation protein 1
(AP1) and Signal Transducers and Activators of Tran-
scription (STAT) families of transcription factors (Figure 5
and Additional file 15). We did not detect any centrally
enriched motifs that might indicate a cooperative binding
partner (that is, a heterodimer) for DNA-bound GRα or
A477T. Nonetheless, previous studies [22] indicate that
there is widespread co-association among transcription
factor binding sites, indicating that nearby sites may be
functional.
Using DREME, we identified a STAT-like motif
(CWGGAA) in 233 and 251 of 1,000 GBRs occupied
by GRα alone, or GRα and A477T, respectively; a dif-
ferent STAT-like motif (GGAAYG) was found in 117 of
1,000 GBRs occupied by A477T alone (Table 1). AP1-
like motifs, STGAGTCA and ATGABTCA, were posi-
tively identified in 35 of 1,000 GBRs occupied by GRα
alone, and 105 of 1,000 GBRs occupied by GRα and
A477T, respectively; AP1-like motifs were not significantly
enriched at GBRs occupied by A477T alone (Table 1). Of
all 23,525 GBRs found in cells expressing GRα, we found
that 1,719 and 1,214 had STAT3 (a canonical member of
the STAT family) or AP1 motifs, respectively, but lacked
GR full sites, and 3,277 and 3,694 had STAT3 or AP1 motifs,
respectively, and contained GR full (see Additional file 10,
Additional file 12, and Table 2).
GR interacts physically and functionally with both the
STAT and AP1 families of transcription factors [23]. Al-
though GR:AP1 interaction is known to be stimulated by
lipopolysaccharide (LPS) treatment, GR also interacts
with AP1 under normal conditions [24]. The presence of
AP1 and STAT motifs at GBRs is consistent with both
‘tethering’ of GR - protein:protein association of GR with
DNA-bound AP1 or STAT - and with the existence of
composite elements, elements that contain binding sitesTable 1 Occurrences of STAT and AP1 motifs found using
DREME.
Found at GBRs in
cells expressing
GRα GRα and A477T A477T
STAT motif CWGGAA CWGGAA GGAAYG
Of 1,000 with motif (n) 233 251 117
AP1 motif STGAGTCA ATGABTCA (NA)
Of 1,000 with motif (n) 35 105 0
Found by DREME within training set of 1,000 peaks (see Figure 5 and
Additional file 10).for GR, and for one or more additional transcriptional
regulatory factors. The greater abundances of GBRs that
contained STAT3 or AP1 motifs and also GR full sites as
compared to GBRs that contained these motifs and lacked
GR full sites (1.4- and 3.0-fold, respectively; Table 2) im-
plies that composite elements may be more common than
tethering elements.
A subset of genes regulated by GRα contains only half
sites
Motivated by the discovery of a half site motif near genes
regulated by A477T, we investigated whether any genes
were regulated by GRα recognition of half site motifs. We
identified a set of genes whose regulation at 4 h is similar
(less than two-fold different) between GRα and A477T at
the 95% confidence levelc. GBR occupancy near these
‘non-selective’ genes (Additional file 15) did not reveal sig-
nificant enrichment of GRα- or A477T-selectively occu-
pied GBRs relative to genes that are selectively regulated,
suggesting that GBRs near these genes are bound by both
GRα and A477T. Consistent with this explanation, GRα
and A477T bind specifically and with equal affinity to half
sites in vitro [4].
We investigated whether GBRs within 20 kilo-base pairs
(kb) of the transcriptional start site of non-selective, acti-
vated genes contained half sites, full sites, or both. Since
the sets of sequences described by the full site motif and
by the half site motif are partially overlapping (Figure 6A),
we assessed the individual information, a quantitative and
absolute measurement of the similarity of a sequence to a
given motif [25], of the best match to each GR motif
(GRα-derived full site motif and A477T-derived half site
motif ) at each GBR (±75 bp from the signal summit; Add-
itional file 12 and Additional file 16). Consistent with the
observed differential occupancy, genes that lost activation
with A477T generally had GBRs that contained GR motifs
that are good full sites (Figure 6B), which logically also
constitute good half sites. Inversely, genes that gained acti-
vation with A477T had GBRs that contained poor full
sites and good half sites. Non-selective genes also had
GBRs that contained poor full sites and good half sites,
suggesting that GBRs near non-selective genes, like those
near genes that gained activation, are bound by GRα at
half sites (Figure 6B).
Next, we investigated whether there were GRα-regulated
genes bearing half site GBRs and apparently lacking full
Figure 6 GR half sites predominate at GBRs near non-selective,
activated genes. (A) More 17mers containing half sites (green
circle) than full sites (red circle) are expected because the
information-containing region of the motif is shorter; similarly,
most full sites contain a good half site because the constraints
(that is, the sequence motifs) are similar and there are two positions
available in a full site for a good half site due to the palindromic nature
of dimer. Nonetheless, not all full sites contain half sites, as the half site
motif is more strongly constrained than the full site motif; the additional
specificity may be due to the lack of cooperative binding at these sites.
(B) Individual information (measured in bits) of the best full site (x-axis)
and half site (y-axis) found at GBRs (circles) located within 20 kb of the
transcriptional start sites of a set of genes; contour lines encompass
same number of GBRs, and thus localize regions of high GBR density.
Genes that lost activation with A477T (B, red) generally had peaks with
good full sites (>10 bits) and good half sites (>9 bits). Genes that gained
activation with A477T (B, green) generally had GBRs with poor full sites
(<5 bits) and good half-sites (>10 bits). Genes that were non-selectivelyc
activated (B, blue) also generally had GBRs with poor full sites and good
half sites.
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restrictive criterion should define genes most likely to be
regulated by GRα via half sites. We did not restrict our se-
lection with respect to regulation by A477T, as some
genes regulated by half sites might not be regulated by
A477T due to impaired conformational dynamics and/or
co-regulator recruitment. We defined as a full site motif
any sequence with an individual information of at least
8.94 bits (the 95th percentile of randomly permuted GBR
sequences), and as a half site motif any sequence with an
individual information of at least 8.00 bits, with respect to
the given motif. By comparison, the full site and half site
motifs had 11.9 bits and 9.3 bits of information, respect-
ively, relative to GBR background sequence (Additional
file 15). We additionally required that the full site motif ’s
individual information at candidate GBRs be less than the
half site motif ’s individual information. In total, there were
1,441 GRα-regulated genes, 607 (42%) of which had asso-
ciated GBRs within 20 kb of the transcriptional start site.
We found that 35 of these 607 genes met our definition,
and that this number declined slowly with an increasing
window of association (27 within 30 kb, 21 within 40 kb,
17 within 50 kb).
GRα monomers bind half sites in vitro
We next investigated the in vitro binding of glucocorticoid
receptor DNA binding domain (DBD) to an oligonucleo-
tide containing a half site adjacent to an ‘anti-motif ’ -
that is, the least favorable binding sequence according
to the half site motif - (gtacAGAACAtttGTGAGGtcgac)
by electrophoretic mobility shift assay [4]. GRα binding
was fitted with the Hill equation and a Hill coefficient of
1.080 ± 0.065 (mean ± standard deviation) was determined
(Figure 7A), consistent with no cooperativity. This indicates
Figure 7 GRα binds a half site in distinct conformation. Hill plot derived from an electrophoretic mobility shift assay describing the fraction of
oligonucleotides containing a half site with an adjacent ‘anti-motif’ - that is, the least favorable binding sequence according to the half site motif
-(gtacAGAACAtttGTGAGGtcgac) bound at increasing GRα concentrations [4]. The Hill coefficient was computed from the Hill Equation (right) to
be 1.080 ± 0.065.
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sequence is bound by GRα as a monomer.
Discussion
Half site motifs suggest GR monomers bind DNA and
regulate specific genes
We set out to find whether sequence motifs bound by
GR might be decomposed into multiple specific motifs
that each relate to the utilization of specific functional
surfaces of GR. We found that A477T, a mutation in the
dimerization interface of GR leading to reduced DNA-
binding cooperativity and increased dissociation rates
in vitro [4], resulted in gains and losses in glucocorticoid-
induced gene regulation and in GBR occupancy in vivo.
Analysis of A477T-occupied GBRs revealed a hitherto
unrecognized half site motif. The half site motif, coupled
with a failure to detect non-GR partner motifs, suggested
that A477T might bind GBRs as a monomer in vivo. Fur-
thermore, A477T regulated many genes, suggesting that
GR monomers are sufficient for gene regulation. The
question remains, then, whether GRα monomers bind to
DNA in a sequence-specific manner and regulate a set of
target genes.
Curiously, we found that some genes were regulated
by A477T and not by GRα, and some GBRs were occu-
pied by A477T and not by GRα. We speculate that GRα
fails to bind such GBRs because it is titrated away by co-
operatively bound, high affinity full sites, composed of
‘degenerate’ or weak half sites; such cooperatively bound
sites would be unavailable to A477T due to its reduced
cooperativity. Indeed, many GRα-selectively occupied
GBRs near GRα-selectively regulated genes contained
full sites lacking ‘consensus’ or perfect half sites; rather,
these full sites were composed of two degenerate half
sites (Figure 6). These results suggest two orthogonal
binding modes for GRα: (1) consensus half sites, most
likely bound by monomers; and (2) degenerate full
sites, most likely bound by dimers.
Alternatively, GRα occupancy may not be observed at
A477T-specific GBRs because GRα dissociates from these
regions more rapidly than A477T, reducing the signalbelow detection limits. However, A477T dissociates
from DNA more rapidly than GRα in vitro [4] and
in vivo [26], arguing against this model. Importantly, at
any given site, some fraction of binding events may in-
volve monomers and some fraction may involve dimers.
We found that a minimum of 35 genes are regulated en-
tirely by direct binding of GRα monomers. While many
genes may be regulated entirely by direct, cooperative
binding of GRα as a dimer, our results suggest that others
may be regulated in part by monomers and in part by
dimers.
Additionally, we found that GBRs were enriched within
20 kb from the promoters of regulated genes (relative to
the whole genome), suggesting that promoter-proximal
GBRs were responsible for many observed changes in
gene expression. Similarly, we found that GRα- and
A477T-selectively occupied GBRs were enriched near
the promoters of genes that lost and gained activation,
respectively, with A477T, consistent with these GBRs
being responsible for gene regulation. Nonetheless,
more than half of GBRs were located distal to genes
(more than 50 kb from the transcriptional start site),
and only 42% of GRα-regulated genes were associated
with promoter-proximal GBRs (±20 kb). Further ex-
ploration is needed to understand the function (if any)
of distal GBRs.
Monomeric GRα is functional in regulation
The ability of a transcription factor to function in gene
regulation alternatively as a monomer or a dimer has
been previously observed for SRY (sex determining re-
gion Y)-box 10 (SOX10) [27]. There are several lines of
evidence suggesting that GRα, too, binds DNA alterna-
tively as a monomer or a dimer. GRα and A477T bind
specifically and with equal affinity to half sites in vitro
[4], with a Hill coefficient of approximately 1, consistent
with binding as a monomer to half sites. Additionally,
single-molecule imaging of GR binding in vivo indicates
that A477T dissociates from DNA 10-fold faster than
GRα [26], consistent with the observation that A477T
has reduced cooperativity when binding full sites in vitro
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a monomer in vivo. Furthermore, deep sequencing of
DNase I-treated chromatin, in combination with ChIP-
seq, reveals that hormone-induced binding of androgen
receptor (AR, HUGO symbol NR3C4), a related nuclear
receptor, was associated with DNase footprints the size
of AR monomers at two-thirds of binding regions [28].
Given the significant homology between AR and GR,
these results suggest that GRα is also capable of binding
as a monomer in vivo.
DNase footprints measured in aggregate, and even dir-
ect imaging of individual binding events, are insufficient
to demonstrate that certain GBR binding events promote
regulation of target genes. Joint measurements of gene ex-
pression and GBR occupancy are the minimum necessary
data to infer function of GBRs. Our finding that at least 35
regulated genes contain only GBRs with half sites within
20 kb of their transcriptional start site provides the best
evidence to date that GRα binds as a functional monomer
in vivo, resulting in regulation of target genes.
Implications of GR monomers for physiology
If GR and other nuclear receptors bind DNA alterna-
tively as dimers or as monomers, then these two recep-
tor species may represent distinct drug targets [29].
Glucocorticoids, like other steroid hormones, regulate
diverse aspects of physiology, making them potent but
blunt tools for medicine. Significant interest in ‘selective’
or ‘dissociated’ glucocorticoid receptor agonists [30,31]
that separate the beneficial and adverse clinical effects of
glucocorticoid treatment has been driven by the success
of similar drugs targeting the estrogen receptor, especially
in treating breast cancer and osteoporosis [32]. Drugs
targeting nuclear receptors commonly bind to a pocket
in the ligand binding domain, normally bound by an en-
dogenous hormone (cortisol in the case of human GR).
Alternatively targeting the dimerization interface or DNA-
binding interface to separate dimer and monomer activity
may help produce improved selective modulators for GR
and other receptors.
Encouragingly, drugs modulating AR conformation
and activity, subsequent to hormone binding, have been
previously found [33]. Our data make it difficult to infer
the potential effects of such selective modulators on GR
activity. However, observations of mice harboring the
equivalent mutation to A477T indicate that inhibiting
GR dimerization may prevent glucocorticoid-induced
decreases in skin and bone collagen synthesis, as well as
decreases in insulin sensitivity, while maintaining or
even exaggerating glucocorticoid-induced increases in
triglyceride synthesis [29]. Moreover, such an inhibitor
may cause an increase in lipogenesis, possibly due to the
regulation (by monomers) of target genes not normally
regulated by GR [29]. A selective modulator that inhibitsthe regulatory function of GR dimers may have different
effects from one that inhibits their formation; both would
inhibit regulation of dimerization-dependent genes, but
the latter may also drive regulation of new target genes,
similar to those observed in the dimerization interface
mutant.
Evolution and structure of hormone-regulated gene
networks
Evidence for existence of functional AR [28] and GR
monomers bound to consensus half sites suggests that
similar monomeric forms may exist for all nuclear re-
ceptor subfamily 3 group C transcription factors (GR,
mineralocorticoid receptor, progesterone receptor, and
AR), and possibly more distantly related nuclear receptors.
These results may have important implications for how
hormone-regulated gene networks evolved. Binding of re-
ceptor monomers to consensus half sites may present an
evolutionary path for establishing robust response ele-
ments wherein one perfect half site appears, at random or
by insertion or rearrangement, and allows for regulation
by monomers, while also promoting selection of a second
site with the proper spacing for cooperative binding by di-
mers; the full site would then be resistant to mutations
that might have perturbed binding by monomers. Alterna-
tively, the half site may have preferred function, and may
therefore remain stable. Analysis of mutations equivalent
to A477T in other nuclear receptors and cell lines may
help clarify the functional and evolutionary role of half
sites.
Additionally, other GR functional surfaces, including
but not limited to AF1, AF2, and the lever arm, may be
associated with more narrowly defined motifs that may
either be subsets of the full site GBS motif, or may differ
from it. Such motifs may be detected by analyzing differ-
entially occupied GBRs near regulated genes selectively
affected by perturbations to a functional surface. In cases
where binding is not perturbed, discriminatory motif
analysis between GBRs proximal to differentially regulated
genes and GBRs proximal to non-selectively regulated
genes may yield similar answers.
Moreover, structural methods such as X-ray crystallog-
raphy, electron microscopy, and NMR may define directly
the conformational changes induced in GR upon binding
to these motifs. These approaches may confirm that GR
binding to a suspected ‘sub-motif ’ induces changes in
the functional surface being studied and drives allo-
steric changes in remote functional surfaces.
Conclusions
GREs differ in their precise sequence motifs, in their
modes of GR binding (monomer or dimer; direct or in-
direct), and in the functional GR surfaces required for
binding or regulation. Structural changes induced in GR
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nonical motif ) may be important determinants of GR ac-
tivity at particular response elements. We have shown that
GR occupies in vivo many genomic regions containing
half sites, and that these regions are likely responsible for
regulation of a subset of target genes. Moreover, GR spe-
cifically binds to half sites in vitro, without apparent coop-
erativity, and thus as a monomer.
Half sites are easily overlooked among those sequences
that conform to the known GR full site motif, but they
have distinct functional properties compared to degener-
ate full sites, which may be predicted to bind with similar
affinity. Identification of GREs with other sub-motifs, the
conformations those GREs induce, and the functional sur-
faces they utilize will be important steps in defining pre-
dictive models of GR activity and in developing therapeutic
strategies to modulate GR activity.
Materials and methods
Cell culture
U2OS cells stably transfected with rat GRα, GRα 30iiB
(30iiB; E219K/F220L/W234R), GRα A477T (A477T), GRγ,
or GRα E773R (E773R) were grown as previously described
[2]. Parent U2OS cells do not manifest any endogenous re-
sponse to glucocorticoid treatment. DNA sequencing ana-
lysis was used to confirm the presence of point mutations
in all cell lines. A549 cells were obtained from American
Type Culture Collection and maintained in DMEM sup-
plemented with 10% volume/volume (v/v) fetal bovine
serum.
Immunoblotting
Whole cell extracts were collected using 20 mM Tris-Cl
pH 8.0, 150 mM NaCl, 1% NonidetP-40 (NP-40), 1% so-
dium deoxycholate, 0.1% sodium dodecyl sulphate (SDS),
2 mM ethylenediaminetetraacetic acid (EDTA). Immunoblot
analysis was performed as previously described [34]. Anti-
bodies to GR (N499) and β-actin (Sigma-Aldrich) were used.
Gene expression measurements using microarrays
Cells were plated in 6-well plates using DMEM supple-
mented with 5% v/v fetal bovine serum. Dexamethasone
(Sigma) at a final concentration of 100 nM was added to
the medium for 2, 4, or 24 h; for the ‘0 h’ time point,
cells were treated with vehicle (ethanol) only for 4 h.
Cells were lysed and total RNA was isolated using
QIAshredder and RNeasy mini columns (Qiagen). The
quality of RNA samples was evaluated by A260/A280 ra-
tio which was at least 1.9 and the integrity was analyzed
using the Bioanalyzer 2100 (Agilent) with the Experion
RNA Stdsens analysis kit (Biorad). For each experimen-
tal condition 2 μg of high quality total RNA was submit-
ted to the University of Southern California Epigenome
Center. Four biological replicates of each experimentalsample from independent experiments that were col-
lected on different days were randomly placed on Illu-
mina Human Ref8 beadchips and processed following
standard Illumina procedures.
Genome build
All coordinates reported are for the UCSC human gen-
ome build hg19 (GRCh37).
Computational analysis of gene expression data
Bead-level data outputted from Illumina’s BeadScan soft-
ware were read using the beadarray package [35] from
Bioconductor [36] with the R programming language [37].
BASH [38] was used to correct for compact and diffuse
spatial artifacts on the arrays. Bead-level data were sum-
marized using beadarray, filtering out beads that were
more than three mean absolute deviations from the me-
dian. Probe annotations were retrieved using the illumina-
Humanv3.db package from Bioconductor; poor quality
probes and probes not corresponding to known HUGO
gene symbols were removed from the data before further
processing. Bead summary data were log2 transformed
and quantile normalized. We then used the non-parametric
empirical Bayes method described by [39] to correct for
chip-to-chip batch effects. The raw data and batch-
corrected, normalized data have been deposited in NCBI’s
Gene Expression Omnibus [40] and are accessible through
GEO Series accession number GSE45407 [41].
The limma package [7] from Bioconductor was used
to determine differential gene expression/regulation: the
lmFit function was used to determine relative expres-
sion at each condition (time point, expressed allele); the
contrasts.fit function was used twice, first to determine
fold-change at 2, 4, and 24 h relative to the ‘0 h’ time
point (4 h ethanol treatment), and second to determine
the difference in fold-change between each expressed al-
lele and GRα; the eBayes function was used to compute
statistics in each case. An adjusted [42] P value cutoff of
P <0.05 was used to determine which genes are differen-
tially expressed. We found there was insufficient statis-
tical power to identify many differentially regulated
genes at 2 h. This is likely due in part to the limitations
of measuring steady state total RNA levels rather than
newly generated transcripts, which was not feasible at
the time of this study. The ggplot2 package [43] was used
to visualize the results. For a more detailed procedure see
(Additional file 17).
Chromatin immunoprecipitation (ChIP)
U2OS cells stably expressing one of GRα, A477T, 30iiB,
or E773R were grown in 3× 75 cm2 dishes and treated
with 100 nM dexamethasone for 90 min. The following
procedure is adapted from [19]. We added formaldehyde
to a final concentration of 1% for 3 min at room temperature
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centration of 125 mM glycine. Cells were incubated at 4°C
for 10 min and then washed with PBS for 5 min. We
added 5 mL ice-cold IP lysis buffer (50 mM HEPES-KOH
pH 7.4, 1 mM EDTA, 150 mM NaCl, 10% v/v glycerol,
0.5% v/v Triton X-100) with 1× protease inhibitor cocktail
added (PIC; Roche Complete) to each flask to lyse cells
and scraped cells into 50 mL conical tubes. Lysed cells
were nutated for 30 min and pelleted by centrifugation at
4°C for 5 min at 600 times gravity. After removing the
supernatant, nuclei were resuspended in 900 μL RIPA buf-
fer (10 mM Tris pH 8.0, 1 mM EDTA, 150 mM NaCl,
5% v/v glycerol, 0.1% sodium deoxycholate, 0.1% SDS,
1% v/v Triton X-100) with 1× PIC added and frozen
at −80°C.
The remaining ChIP procedure was performed at 4°C.
Protein G Dynabeads (Invitrogen) were prepared for IP
as follows: beads were pelleted (using a magnet); liquid
was removed; beads were washed twice with RIPA, then
resuspended in RIPA with 1× PIC and 0.5 mg/mL BSA
at the original bead concentration; 12 μg N499 α-GR
antibody were added per 100 μL beads, and the beads
were nutated for 2 h.
Nuclei were thawed in ice water. Chromatin from nuclei
were fragmented by sonication at 4°C in 300 μL aliquots
in 1.5 mL microcentrifuge tubes using the Diagenode
Biorupter for 8 cycles of 7 min (0.5 min on / 0.5 min off).
Samples were spun at 14,000 revolutions per minute
(rpm) and for 15 min to pellet insoluble molecules, and
the supernatant was transferred into new microcentrifuge
tubes. We saved 10% of each sample to isolate later as in-
put DNA (GRα and A477T only). Protein G Dynabeads
with antibody bound were pelleted, washed twice with
RIPA, and resuspended at the original bead concentration
in RIPA with 4× PIC and 2 mg/mL BSA. Sonicated chro-
matin (900 μL) from each sample was incubated with
100 μL of antibody-bound beads for 16 h.
After pulldown, beads were washed four times with
RIPA with 500 mM NaCl, then four times with LiCl buffer
(20 mM Tris, 1 mM EDTA, 250 mM LiCl, 0.5% NP-40,
0.5% sodium deoxycholate), to decrease non-specific bind-
ing. To reverse crosslinks, beads were then resuspended
in 11 μL RIPA with 500 mM NaCl plus 89 μL Rev-Xlink
buffer (0.7% SDS in TE pH 8.0 with 0.2 mg/mL Proteinase
K). A total of 10 μL of each input DNA sample was simi-
larly treated by adding 1 μL 5 M NaCl and 89 μL Rev-
Xlink buffer. Samples were incubated in a PCR block at
55°C for 3 h, then 16°C for 16 h, then column purified
using the Clean & Concentrator-5 kit (Zymogen) at a
DNA binding buffer:sample ratio of 5:1.
Library preparation for ChIP sequencing (ChIP-seq)
Fragments were end-repaired for 30 min at 20°C in
25 μL reactions with 1× T4 DNA Ligase Buffer w/ 10 mMATP (NEB), 100 uM dNTPs (Invitrogen), 3.75 U T4
DNA Polymerase (NEB), 1.25 U DNA Polymerase I, Large
(Klenow) Fragment (NEB), and 12.5 U T4 Polynucleotidse
Kinase. Samples were column purified using the Clean &
Concentrator-5 kit (Zymogen) at a DNA binding buffer:
sample ratio of 2:1 following this and subsequent enzym-
atic reactions. dATP was added to the 3’ end of molecules
by incubating for 30 min at 37°C in 25 μL reactions with
Buffer 2 (NEB), 200 uM dATP (Invitrogen), and 7.5 U Kle-
now Fragment (3’- > 5’ exo-). Sample concentrations were
measured using PicoGreen (Invitrogen), and then ligated
to sequencing adapters at a 2:1 (adapter:sample) molar ra-
tio in 20 μL reactions with 1X T4 DNA ligase buffer w/
10 mM ATP (NEB) with 6% PEG-8000 and 200 U T4
DNA Ligase (NEB). Libraries were amplified by PCR for
17 cycles using the standard Illumina paired-end primers,
and purified by PAGE as described in [44]. Sample con-
centrations and size distribution were measured using the
High Sensitivity DNA kit for the Bioanalyzer 2100 (Agi-
lent) prior to sequencing.
Adapters and barcodes for ChIP-seq
In-house barcodes were used for ChIP samples, which
were added to the 3’ ends of the sequencing adapters and
determined using the first four bases of the read. Barcodes
are TCAT (BC1), GACG (BC2), AGTC (BC3), and CTGA
(BC4). The ChIPs for GRα and A477T were each ligated
to all barcodes, pooled, and sequenced in their own lanes.
Samples for 30iiB and E773R were ligated to BC1-2 and
BC3-4, respectively, and pooled. Input samples were li-
gated to indexed TruSeq adapters using indices 5 and 7
for GRα and A477T inputs, respectively.
ChIP-seq procedure
ChIP samples were sequenced at the University of California
San Francisco Center for Advanced Technology using the
Genome Analyzer II (Illumina) with 2× 75 bp paired end
reads as per the manufacturer’s instructions. Input DNA
samples were sequenced using the HiSeq 2000 (Illumina)
with 2× 100 bp paired end reads. Raw sequence reads
were deposited in the Sequence Read Archive (SRA) at
the National Center for Biotechnology Information
(NCBI) [45] and are accessible through SRA study ac-
cession number SRP020242.
Computational analysis of ChIP-seq data
We automated the analysis procedure using the Python
programming language in order to make our results easily
reproducible and to facilitate similar analysis by others.
The scripts used - preprocess_reads.py, align2.py, call_-
peaks.py, and analyze.py - are described here and are avail-
able in the software package seriesoftubes on the Python
Package Index (PyPI). seriesoftubes depends in part on
Biopython [46]. We used preprocess_reads.py (seriesoftubes)
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ing only reads with valid barcodes/indices (on both ends
in a pair for internal barcodes), and merged barcodes/indi-
ces as applicable to consolidate sequence data for each
sample. We then used align2.py (seriesoftubes) to align se-
quences to the genome using bowtie2 [47], allowing a
maximum insert size of 600 bp (based on our observation
of an average library size of <150 bp) and saved in BAM
format using samtools [48]. Note: for internal barcodes,
the first five bases contain the barcode plus an additional
‘T’; these positions were ignored when running bowtie2.
We used call_peaks.py (seriesoftubes), which relies on
the MACS2a callpeak module, to find significantly occu-
pied peak regions (‘peaks’) and summit positions using
an adjusted P value cutoff of P <0.01 and to generate
pileup tracks (signal per million reads). Additionally, the
MACS2 diffstats module was used to compute differen-
tial occupancy statistics and find (mutant versus GRα)
differentially occupied peaks at using an adjusted P
value cutoff of P <0.05. For convenience, we have created
a track hub formatted for the UCSC genome browser [49]
containing paired-end read alignments, signal pileups,
peak region locations, and peak summit locations [50].GBR to gene assignment
Peaks were assigned to genes using GREAT [9], with a
basal domain of ±20 kb of a gene’s primary transcrip-
tional start site (where assignment is guaranteed) and an
extended domain of ±100 kb (where assignment is made
only if it does not overlap with another gene’s basal do-
main); if a peak was assigned to multiple genes, it was
ignored in subsequent analyses.Motif analysis
MEME-ChIP [16] was used for motif discovery as de-
scribed in the text. For all motif analyses, we used only
peak regions (±75 bp from the peak summit) that do not
overlap with repeats, found by using bedtools [51] to
intersect peaks regions with the ‘rmsk’ table from the
RepeatMasker [52] track for hg19, extracted using the
Table Browser [53]. Peak sequences (±75 bp from the peak
summit) were then extracted from the UCSC hg19 build
of the human genome using the twobitreader package
(available on PyPI). Occurrences of motifs were found
using analyze.py (seriesoftubes), which relies on MOODS
[54] for efficiency. JASPAR [55] motifs MA0144.1 and
MA0099.2 were used to find STAT3 and AP1 sites, re-
spectively. Peak sequences were randomly permuted and
the 95th percentile of individual information for the best
motif in each permuted peak sequence was used as a
cutoff for determining presence of GR full site, STAT3,
or AP1 motifs (8.94, 8.06, and 9.49 bits, respectively).
Data were integrated for further analysis using the Rprogramming language (Additional file 10) and visualized
with ggplot2 [43].
Luciferase transcriptional reporters
Selected GR binding regions were cloned into the firefly
luciferase reporter vector pGL4.10-E4TATAd using con-
ventional methods (that is, PCR and restriction enzymes).
A table of reporter names, primers, and genomic coordi-
nates is provided in Additional file 18. We used the
Renilla luciferase reporter vector pGL4.70-MLE2e as a
normalization control, and the mammalian expression
vector p6R as ‘filler’ DNA to reach the recommended
concentration of DNA for transfections.
U2OS cells stably expressing either GRα or A477T
were grown in three 10 cm dishes each, split, and seeded
into two 96-well plates at a final density of about 5 × 104
cells/well. The next day, cells were transfected with
3.33 ng firefly reporter, 150 pg Renilla reporter, and
20 ng p6R per well using PLUS Reagent and Lipofecta-
mine (Invitrogen) according to manufacturer instructions.
After 16 h, cells were treated with 100 nM dexamethasone
or vehicle only (ethanol) for 3 h, and then luciferase ex-
pression was assayed using the Dual-Luciferase Reporter
Assay System (Promega) according to manufacturer’s
instructions.
Endnotes
aMACS2 will be described in more detail in a forth-
coming publication. Briefly, peak calling uses a Poisson
test as in the first version of MACS [56] and differential
occupancies are determined using a log-likelihood ratio
test, and transformed to P values using Wilks’ theorem
[57]. Pre-release versions of MACS2 are available online
at [58].
bGBRs with different locations among two samples
were determined as those GBRs that were detectable in
one sample and not the other (by overlap) and that did
not significantly differ in occupancy among the two sam-
ples. This quantification of GBRs with differing locations
is only an estimate, as some GBRs that differ in occupancy
may appear to have similar occupancy. This effect results
from variation in the observed numbers at a given GBR,
primarily due to Poisson counting error.
cTo determine whether fold-changes in gene expression
between two conditions were less than two-fold different
at a significance level of 95%, we constructed 97.5% confi-
dence intervals for the fold-change in gene expression
under each condition and required that they do not over-
lap at all. The 97.5% confidence intervals were computed
as the fold-change plus or minus 2.447 - the t-statistic for
six degrees of freedom (eight total sample measurements
minus two degrees for determining their respective means) -
divided by the square root of two (because subtracting
two groups of four yields an equivalent n of 2), and
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given gene as determined by limma.
dpGL4.10-E4TATA was constructed by ligating the
E4TATA minimal promoter 5’-tttttagtcc tatatatact cgctctgtac
ttggcccttt ttacactgtg to the promoter-less vector pGL4.10
at BglII and HindIII restriction sites. The E4TATA pro-
moter was selected because it does not respond to
dexamethasone.
epGL4.70-MLE2 was constructed by ligating the MLE2
promoter (engineered ML promoter with stronger induc-
tion ability) 5’-gaaggggggc tataaaaact cgctctggcg cgttcgtcct
cactctcttc cgcatcgct. The MLE2 promoter was chosen
because it does not respond to dexamethasone and drives
strong expression.Additional files
Additional file 1: Genome-wide expression analysis. Compressed
folder (zip archive) containing the following tab-delimited text files with
probe-wise results of gene expression analysis using limma, including
statistics and gene-level annotations: Expression_Levels_log2.txt, expression
levels at all conditions; Fold-changes_vs_0hr_log2.txt, relative gene expression
in all cell lines after 2, 4, and 24 h of dexamethasone treatment versus ‘0 hours’;
Fold-difference_vs_GRα_2hr_log2.txt, difference in regulation (changes
in gene expression) after 2 h of dexamethasone treatment in cells expressing
A477T, 30iiB, E773R, or GRγ versus regulation in cells expressing GRα; ‘Fold-
difference_vs_GRα_4hr_log2.txt’ and ‘Fold-difference_vs_GRα_24hr_log2.txt’,
same as ‘Fold-difference_vs_GRα_2hr_log2.txt’ but after 4 and 24 h of
dexamethasone treatment, respectively. Low quality and non-genic
probes have been removed.
Additional file 2: Genome-wide description of GR binding regions
(GBRs). gzip-compressed tarball (.tar.gz file) containing tab-delimited text
files and BED files (UCSC format), created with MACS2, describing significantly
enriched GBRs from ChIP-seq data for GRα (GR-WT), A477T (GR-Dim), 30iiB
(GR-AF1), E773R (GR-AF2). Each allele is organized into a folder that contains
three files (named as described above): [NAME]_peaks.bed and [NAME]_sum-
mits.bed files contain peak/GBR locations and (signal peak) summit locations
as BED files, respectively, and [NAME]_peaks.xls files describing statistics about
each peak. Chromosomal coordinates in .xls files start with 1 and intervals
contain both the start and end position.
Additional file 3: Assignments of GBRs to genes (GREAT output).
Gzip-compressed tarball (.tar.gz file) containing tab-delimited text files
with assignments of peaks to genes and vice versa for each GR allele.
Assignments were made with GREAT (see Methods, ‘Analysis of ChIP-seq
data’). Alleles and GBRs are named as in Additional file 2.
Additional file 4: MACS2 analysis of differential occupancy between
GRα and A477T. Tab-delimited text files describe differentially occupied
regions genome-wide or at peaks (GBRs) in each separate sample. Three
files created with MACS2 are provided: GR-WT_vs_GR-Dim_diffpeaks.xls,
which lists all differentially occupied peaks; GR-WT_vs_GR-Dim_diffpeaks_-
by_peaks1.xls and GR-WT_vs_GR-Dim_diffpeaks_by_peaks2.xls, which list all
peaks originally found with GR-Dim/A477T (annotated as sample 1) or
GR-WT/GRα (annotated as sample 2), respectively, and statistics about their
differential occupancy. Chromosomal coordinates in .xls files start with 1
and intervals contain both the start and end position.
Additional file 5: MACS2 analysis of differential occupancy between
GRα and 30iiB. Tab-delimited text files describe differentially occupied
regions genome-wide or at peaks (GBRs) in each separate sample. Three
files created with MACS2 are provided: GR-WT_vs_GR-AF1_diffpeaks.xls,
which lists all differentially occupied peaks; GR-WT_vs_GR-AF1_diffpeaks_-
by_peaks1.xls and GR-WT_vs_GR-AF1_diffpeaks_by_peaks2.xls, which list
all peaks originally found with GR-AF1/30iiB (annotated as sample 1) or
GR-WT/GRα (annotated as sample 2), respectively, and statistics abouttheir differential occupancy. Chromosomal coordinates in .xls files start
with 1 and intervals contain both the start and end position.
Additional file 6: MACS2 analysis of differential occupancy between
GRα and E773R. Tab-delimited text files describe differentially occupied
regions genome-wide or at peaks (GBRs) in each separate sample. Three
files created with MACS2 are provided: GR-WT_vs_GR-AF2_diffpeaks.xls,
which lists all differentially occupied peaks; GR-WT_vs_GR-AF2_diffpeaks_-
by_peaks1.xls and GR-WT_vs_GR-AF2_diffpeaks_by_peaks2.xls, which list
all peaks originally found with GR-AF2/E773R (annotated as sample 1) or
GR-WT/GRα (annotated as sample 2), respectively, and statistics about
their differential occupancy. Chromosomal coordinates in .xls files start
with 1 and intervals contain both the start and end position.
Additional file 7: Pairwise comparisons of GRα GBRs and A477T
GBRs. The comparison includes information about full site and half
motifs, and contains all GBRs from GRα and those GBRs from A477T that
do not overlap with GBRs from GRα. Applicable information is merged
from Additional files 3, 4, 12, and 15. Alleles are named as in Additional
file 2. See Additional file 17 for details about the construction of these
files.
Additional file 8: Pairwise comparisons of GRα GBRs and 30iiB
GBRs. The comparison contains all GBRs from GRα and those GBRs from
30iiB that do not overlap with GBRs from GRα. Applicable information is
merged from Additional files 3 and 5. Alleles are named as in Additional
file 2. See Additional file 17 for details about the construction of these
files.
Additional file 9: Pairwise comparisons of GRα GBRs and E773R
GBRs. The comparison contains all GBRs from GRα and those GBRs from
E773R that do not overlap with GBRs from GRα. Applicable information is
merged from Additional files 3 and 6. Alleles are named as in Additional
file 2. See Additional file 17 for details about the construction of these
files.
Additional file 10: R script for GBR analysis (text file). Assembly of
Additional files 7 and 8 and combination of gene expression data
(Additional file 1) with occupancy data. See Materials and Methods,
‘Computational analysis of ChIP-seq data’ for details. Execution requires R
<http://www.r-project.org/>.
Additional file 11: GBR positions and strengths of occupancy at
genes that lost activation with A477T. Genes are aligned at their
transcription start sites with coding regions in the plus direction and
promoter regions in the minus direction. GBRs are indicated as circles;
size indicates the magnitude of occupancy; color indicates differential
occupancy: blue indicates more binding by A477T and yellow indicates
more binding by GRα. A yellow box from −20 kb to +20 kb indicates
where there is significant enrichment of GRα-selective GBRs.
Additional file 12: Motif information at GBRs occupied by GRα or
A477T. Gzip-compressed tarballs containing tab-delimited text files with
information about the best match to the full site or half site motifs at
GBRs occupied by GRα or A477T. Additionally, there are files containing
STAT3 (MA0144.1) and AP1 (MA0099.2) for GBRs occupied by GRα. Alleles
are named as in Additional file 2.
Additional file 13: GBR positions and strengths of occupancy at
genes that gained activation with A477T. Blue box from −20 kb to
+20 kb indicates region of significant enrichment of GRα-selectively occupied
GBRs. See Additional file 7 legend for further description of features.
Additional file 14: GRα and A477T selectively activate transcription
with transcriptional reporters containing selectively occupied GBRs.
(A) Selected GBRs (approximately 500 bp, centered on the signal
maximum) were cloned into a luciferase-based transcriptional reporter
and transfected into U2OS cells expressing either GRα or A477T. (B) GBRs
were selected on the basis of proximity to activated genes, strength of
occupancy, and isolation from many other GBRs : GRα-selectively occupied
GBRs proximal to GRα-selectively activated genes; A477T-selectively
occupied GBRs proximal to A477T-selectively activated GBRs genes
(with the exception of HOXD1_GRE1, which showed GRα-selective
occupancy); and non-selectively occupied GBRs proximal to non-
selectively activated genes. GBRs drove GRα-selective activation with
several GRα-selectively occupied GBRs, A477T-selective activation with
Schiller et al. Genome Biology 2014, 15:418 Page 15 of 16
http://genomebiology.com/2014/15/7/418several A477T-selectively occupied GBRs, and non-selective activation
with several non-selectively occupied GBRs. Some GBRs did not activate
transcription in either cell line (for example, KCNA5_GRE1-3), but only two
(HOXD1_GRE1 and CHST15_GRE1) drove aberrant activation (opposing
selectivity of occupancy and activation).
Additional file 15: Motif analysis of selectively and nonselectively
occupied GBRs. Gzip-compressed tarball (.tar.gz file) containing folders
with motif results (MEME-ChIP) for three groups of GBRs, with and without
enforcement of a 17 bp motif in MEME (six folders total). ‘GRα_only’ and
‘GRα_only.17 bp’: the thousand most-occupied GBRs that were occupied by
GRα and did not have detectable occupancy by A477T. ‘GRα_and_A477T’
and ‘GRα_and_A477T.17 bp’: the thousand most-GRα-occupied GBRs that
were occupied by both GRα and A477T with less than a 1.4-fold difference.
‘A477T_only’ and ‘A477T_only.17 bp’: The thousand most-occupied GBRs
that were occupied by A477T and did not have detectable occupancy by
GRα. Each folder contains a file named ‘index.html’, which can be opened in
a web browser to view the results. See Figure 5 for a summary.
Additional file 16: GBR positions and strength of occupancy at
non-selectively activatedc genes. See Additional file 7 legend for a
description of features.
Additional file 17: R script for analysis of gene expression
microarray data (text file). See Materials and Methods, ‘Computational
analysis of gene expression data’ for details. Execution requires R,
available at <http://www.r-project.org/>.
Additional file 18: Table of primers used for reporters.Abbreviations
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